ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 131 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $15,320,000 | +69.9% | 812,247 | +6.0% | 0.03% | +78.9% |
| Q2 2019 | $9,015,000 | +2691.0% | 765,917 | +3135.4% | 0.02% | +1800.0% |
| Q1 2019 | $323,000 | +26.7% | 23,673 | -5.0% | 0.00% | 0.0% |
| Q4 2018 | $255,000 | -38.6% | 24,907 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $415,000 | +1.2% | 24,907 | -4.0% | 0.00% | 0.0% |
| Q2 2018 | $410,000 | +13.6% | 25,956 | -8.6% | 0.00% | 0.0% |
| Q1 2018 | $361,000 | +11.1% | 28,389 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $325,000 | -6.6% | 28,389 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $348,000 | +36.5% | 28,389 | +27.3% | 0.00% | 0.0% |
| Q2 2017 | $255,000 | -40.4% | 22,304 | +8.4% | 0.00% | 0.0% |
| Q1 2017 | $428,000 | 0.0% | 20,570 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $428,000 | -36.5% | 20,570 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $674,000 | +31.1% | 20,570 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $514,000 | +100.0% | 20,570 | +95.9% | 0.00% | 0.0% |
| Q1 2016 | $257,000 | -25.9% | 10,499 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $347,000 | +0.9% | 10,499 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $344,000 | -38.1% | 10,499 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $556,000 | – | 10,499 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $34,629,000 | 11.36% |
| Foresite Capital Management II, LLC | 1,586,220 | $18,670,000 | 10.50% |
| DAFNA Capital Management LLC | 636,013 | $7,486,000 | 2.81% |
| Redmile Group, LLC | 8,244,896 | $97,042,000 | 2.75% |
| Lion Point Capital, LP | 1,204,600 | $14,178,000 | 1.40% |
| Palo Alto Investors LP | 1,861,630 | $21,911,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,517,856 | $41,405,000 | 0.87% |
| Bellevue Group AG | 4,118,806 | $48,478,000 | 0.83% |
| Rock Springs Capital Management LP | 1,562,300 | $18,388,000 | 0.66% |
| Artal Group S.A. | 850,000 | $10,005,000 | 0.40% |